Previous close | 23.53 |
Open | 23.90 |
Bid | 22.14 x 100 |
Ask | 23.55 x 100 |
Day's range | 22.50 - 23.90 |
52-week range | 7.93 - 33.00 |
Volume | |
Avg. volume | 87,353 |
Market cap | 1.216B |
Beta (5Y monthly) | -3.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Pharvaris (PHVS) rises 6% after the FDA lifts the clinical hold on the investigational candidate, deucrictibant, for the prophylactic treatment of HAE attacks.
Key Insights Significant control over Pharvaris by private equity firms implies that the general public has more power...